V. Molecular classification and risk stratification of myeloma - Wikidata - wikimedia - TriplyDB

V. Molecular classification and risk stratification of myeloma

V. Molecular classification and risk stratification of myeloma

http://www.wikidata.org/entity/Q26861396

about

Towards Stratified Medicine in Plasma Cell Myeloma The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma.Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations Three-dimensional Nuclear Telomere Organization in Multiple Myeloma.Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.Genetics in myeloma: genetic technologies and their application to screening approaches in myeloma.Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.Hyperhaploid karyotypes in multiple myeloma.Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event

P2860

Q28074994-5F7AEA1D-9127-4558-B61D-3845B2CF3888 Q33869569-CCDCE1B0-6215-41AE-BE68-08BAD0462527 Q34272540-F5A3F46A-8CDA-4562-9238-017AAC475A73 Q34556156-F8D1F7E8-1E49-4DAB-8D99-1746EBB85D37 Q35081172-D5EA0ED5-F1D6-4A89-B61E-FFD49C64732A Q37474404-BD081B8D-C491-4712-8400-A217F830E9E5 Q37692687-02528D12-0CE2-453E-A845-361C45FBCEDF Q38348173-C0ED7F4F-8C6B-4A14-80DA-C6FE1D6B4ADC Q40492260-E40C65E5-033B-4C5A-B702-777BF30AE71E Q46010686-D5FAF685-01D3-4048-9E6D-88A4BFA202CE Q58754109-DBE53CEE-413D-4211-A3D2-970002A85983

P2860

V. Molecular classification and risk stratification of myeloma

http://www.wikidata.org/entity/Q26861396

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

V. Molecular classification and risk stratification of myeloma

@ast

V. Molecular classification and risk stratification of myeloma

@en

V. Molecular classification and risk stratification of myeloma

@nl

type

label

V. Molecular classification and risk stratification of myeloma

@ast

V. Molecular classification and risk stratification of myeloma

@en

V. Molecular classification and risk stratification of myeloma

@nl

prefLabel

V. Molecular classification and risk stratification of myeloma

@ast

V. Molecular classification and risk stratification of myeloma

@en

V. Molecular classification and risk stratification of myeloma

@nl

P1433

Q26861396-69819C90-D69A-4C30-9166-CD03AAADE88C

P1476

Q26861396-448642CF-0543-4A8B-B5A6-2D9BB48747C9

P2093

Q26861396-5CD39340-C9C0-4443-8D8F-9CB48DDBE7DF

Q26861396-E8523417-F1C7-45F1-B137-D47E1B34DFA4

P2860

Q26861396-2B424259-9A52-48F5-BDE6-E688A9AE7C4F

Q26861396-36D7C5D3-C906-4E68-BD58-D0C2EA76C712

Q26861396-569DA584-E270-43C8-9422-EADE7472A15C

Q26861396-5DAC383C-D61B-4AC1-A363-DE577EA951F5

Q26861396-7AE03440-5888-4A25-8B27-A3E6F3645378

Q26861396-819F7D80-8B2B-4A86-8852-C1A6616E9145

Q26861396-87019A2A-6983-4D28-BC66-FAD70DFBAC9D

Q26861396-8BE8D737-80D2-440A-B247-1E9AEAAA6EC3

Q26861396-8FF0494D-7F4F-4C18-9178-CB7F7253D4CD

Q26861396-98559159-9C35-4730-B403-24BBCE343422

P304

Q26861396-980B6E45-359B-4EFF-8328-2AAC087BC767

P31

Q26861396-80BC9D70-DB50-44F9-8DDC-8644C81220AA

P3181

Q26861396-34655BFE-4334-42D2-A04B-95D1EAC49B73

P356

Q26861396-3F61D909-11D5-4D20-B7E6-722E55A392FE

P407

Q26861396-18CE0173-B224-453A-B351-AC6C9F672C21

P478

Q26861396-EE707B62-EFA8-4867-9A53-99048B455334

P577

Q26861396-4357B0C0-C8E9-42A4-A254-DA4AA7A3CB06

P5875

Q26861396-C2408409-E96C-4E17-A28F-B986C11EB6E7

P698

Q26861396-A8A34B5E-A4FA-4766-A20F-4D8F0E18EEA0

P932

Q26861396-D2C8771E-CFCB-42C5-BF6C-9EE93FB8277E

P3181

P356

P1433

Hematological Oncology

P1476

V. Molecular classification and risk stratification of myeloma

@en

P2093

Marta Chesi

http://www.w3.org/2001/XMLSchema#string

P. Leif Bergsagel

http://www.w3.org/2001/XMLSchema#string

P2860

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

Initial genome sequencing and analysis of multiple myeloma

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites

Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy.

The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.

NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.

Clonal competition with alternating dominance in multiple myeloma.

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

P304

38-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2857231

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HON.2065

http://www.w3.org/2001/XMLSchema#string

P407

P478

31 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239940297

http://www.w3.org/2001/XMLSchema#string

P698

23775647

http://www.w3.org/2001/XMLSchema#string

P932

3941196

http://www.w3.org/2001/XMLSchema#string